Literature DB >> 17804613

Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis.

Glenda Gilmore1, Jodie Barnes, Natkunam Ketheesan, Robert Norton.   

Abstract

The serological diagnosis of melioidosis is carried out using the indirect hemagglutination assay. We looked at the reactivity of sera from culture-proven cases of melioidosis from north Queensland against antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia. Cross-reactivity between sera from culture-positive cases of melioidosis and B. thailandensis was demonstrated.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17804613      PMCID： PMC2168162          DOI： 10.1128/CVI.00197-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  10 in total

1.  Clinical presentation of melioidosis in Queensland, Australia.

Authors:  Agnieszka B Malczewski; Kimberly M Oman; Robert E Norton; Natkunam Ketheesan
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11       Impact factor: 2.184

2.  Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay.

Authors:  Rachaneeporn Tiyawisutsri; Sharon J Peacock; Sayan Langa; Direk Limmathurotsakul; Allen C Cheng; Wirongrong Chierakul; Wipada Chaowagul; Nicholas P J Day; Vanaporn Wuthiekanun
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.

Authors:  P J Brett; D DeShazer; D E Woods
Journal:  Int J Syst Bacteriol       Date:  1998-01

5.  Diagnostic value of the indirect hemagglutination test for melioidosis in an endemic area.

Authors:  H Appassakij; K R Silpapojakul; R Wansit; M Pornpatkul
Journal:  Am J Trop Med Hyg       Date:  1990-03       Impact factor: 2.345

6.  The prevalence of human melioidosis in Northern Queensland.

Authors:  L R Ashdown; R W Guard
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

7.  Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests.

Authors:  A D Alexander; D L Huxsoll; A R Warner; V Shepler; A Dorsey
Journal:  Appl Microbiol       Date:  1970-11

8.  Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis.

Authors:  L R Ashdown; R W Johnson; J M Koehler; C A Cooney
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

9.  Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand.

Authors:  P Kanaphun; N Thirawattanasuk; Y Suputtamongkol; P Naigowit; D A Dance; M D Smith; N J White
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

10.  Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia.

Authors:  Bart J Currie; Susan P Jacups; Allen C Cheng; Dale A Fisher; Nicholas M Anstey; Sarah E Huffam; Vicki L Krause
Journal:  Trop Med Int Health       Date:  2004-11       Impact factor: 2.622
  10 in total
  8 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay.

Authors:  Gemma Robertson; Alanna Sorenson; Brenda Govan; Natkunam Ketheesan; Raymond Houghton; Hongjing Chen; David AuCoin; Michael Dillon; Robert Norton
Journal:  J Med Microbiol       Date:  2015-06-07       Impact factor: 2.472

Review 3.  Glanders: an overview of infection in humans.

Authors:  Kristopher E Van Zandt; Marek T Greer; H Carl Gelhaus
Journal:  Orphanet J Rare Dis       Date:  2013-09-03       Impact factor: 4.123

Review 4.  Melioidosis: Clinical impact and public health threat in the tropics.

Authors:  Ramar Perumal Samy; Bradley G Stiles; Gautam Sethi; Lina H K Lim
Journal:  PLoS Negl Trop Dis       Date:  2017-05-11

5.  Seroprevalence of Burkholderia pseudomallei among Adults in Coastal Areas in Southwestern India.

Authors:  Kalwaje Eshwara Vandana; Chiranjay Mukhopadhyay; Chaitanya Tellapragada; Asha Kamath; Meghan Tipre; Vinod Bhat; Nalini Sathiakumar
Journal:  PLoS Negl Trop Dis       Date:  2016-04-14

6.  Antibodies in Melioidosis: The Role of the Indirect Hemagglutination Assay in Evaluating Patients and Exposed Populations.

Authors:  Panjaporn Chaichana; Kemajittra Jenjaroen; Premjit Amornchai; Suchintana Chumseng; Sayan Langla; Patpong Rongkard; Manutsanun Sumonwiriya; Atthanee Jeeyapant; Narisara Chantratita; Prapit Teparrukkul; Direk Limmathurotsakul; Nicholas P J Day; Vanaporn Wuthiekanun; Susanna J Dunachie
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

7.  Seroepidemiology of Burkholderia pseudomallei, Etiologic Agent of Melioidosis, in the Ouest and Sud-Est Departments of Haiti.

Authors:  Thomas A Weppelmann; Michael H Norris; Michael E von Fricken; Md Siddiqur Rahman Khan; Bernard A Okech; Anthony P Cannella; Herbert P Schweizer; Daniel C Sanford; Apichai Tuanyok
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

8.  Investigation of Melioidosis Using Blood Culture and Indirect Hemagglutination Assay Serology among Patients with Fever, Northern Tanzania.

Authors:  Michael J Maze; Mindy Glass Elrod; Holly M Biggs; John Bonnewell; Manuela Carugati; Alex R Hoffmaster; Bingileki F Lwezaula; Deng B Madut; Venance P Maro; Blandina T Mmbaga; Anne B Morrissey; Wilbrod Saganda; Philoteus Sakasaka; Matthew P Rubach; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2020-09-24       Impact factor: 3.707
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.